Recent Finacing
Recent Raise
InDex Pharmaceuticals is a Stockholm-based clinical-stage biopharmaceutical developing DNA-based immunomodulatory sequences (DIMS), including Kappaproct (TLR9 agonist) for severe ulcerative colitis, and DiBiCol diagnostics.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors